AnaptysBio Phase 2a data breakdown and Biotech portfolio reveal!

-AnaptysBio shows positive phase 2a data from their peanut allergy study with ANB020
https://ir.anaptysbio.com/news-releases/news-release-details/anaptysbio-announces-positive-top-line-proof-concept-data-anb020

-Check out the PRACTALL guidelines for Oral Food Challenges

Click to access Standardizing_DBPCFC_PRACTALL_2012.pdf

-I’m not taking a position because with such a small sample size, and convoluted inclusion criteria, I need to see more data

 

Leave a Reply

%d bloggers like this: